Job Creation

Job Creation
:: New York City has the largest bioscience workforce and
Why Invest?
:: In 2011, New York received more than $2 billion National
Institutes of Health (NIH) grants, which supported 33,193
jobs. More than half went to NYC universities and nonprofit
research centers. Sources: United for Medical Research; Center for an
Urban Future.
:: New York is home to seven of the top 50 American
research universities and two of the top 25 medical
research universities. Source: The Center for Measuring University
Global Health
Research and
Development:
working to
improve
lives at home
and abroad.
Performance, 2010.
:: The state gives a 9% corporate tax break to investment
in R&D facilities. Sources: Empire State Development; R&D Credit Coalition, 2010.
the second largest life sciences workforce of any U.S.
city, employing a combined 80,000 people at an
average wage of $75,700. Source: NYC Economic Development Corp, 2011.
:: Employment in biotechnology R&D increased by 32.6%
from 2007 to 2010 in New York state.
Source: New York Biotechnology Association, 2011.
:: In December 2011, NYC Mayor Bloomberg announced
the creation of a new applied sciences campus on
Roosevelt Island in partnership with Cornell University
and Technion, with federal support. The campus is
expected to generate 600 spin-off companies, up to
38,000 permanent jobs, $23 billion in economic activity
and $1.4 billion in tax revenue. Source: mikebloomberg.com.
:: In 2010, the NY bioscience sector added 3,817 jobs at
an annualized growth rate of over 5.9%. Source: NYBA, 2011.
HEALTH IMPACT
Here are just two examples of the many global health research projects happening at New York universities including Cornell, Pace, SUNY and others.
The Rockefeller University was the nation’s first biomedical research institution. In the
global health arena, the University is recognized for developing meningitis vaccines and
AIDS drug therapy, both used domestically and internationally. Source: Rockefeller University
As many as 100 million people in more than 70 countries are drinking water with
arsenic concentrations up to 100 times the World Health Organization guideline,
which has been shown to lead to disease. The Columbia University
Mailman School of Public Health received a $1.9 million grant
from the National Institutes of Health to predict risk for disease.
Source: Columbia University.
NEW YORK: PRODUCT DEVELOPMENT PARTNERSHIPS
PDPs use a unique, non-profit business model in which public, private, academic and philanthropic sectors partner to accelerate the creation of
drugs, vaccines and diagnostics to advance health. They pave the way for new research and technologies for the most vulnerable populations,
as quickly and cheaply as possible. Three PDPs headquartered in New York are:
Drugs for Neglected Diseases initiative (DNDi) New York; Geneva :: DNDi is establishing a strong R&D portfolio to deliver up to 13 new treatments for neglected
diseases including Chagas, sleeping sickness, leishmaniasis, parasitic-worm diseases, malaria, and pediatric HIV by 2018.
The Global Alliance for TB Drug Development (TB Alliance) New York :: The average TB patient loses 3-4 months of work time and up to 30% of yearly
household earnings due to illness. TB Alliance is leading the search for a better cure with domestic and international R&D partnerships to expedite the process. It
manages the largest, most comprehensive portfolio of TB drug candidates ever and serves as a hub of TB drug development expertise.
The International AIDS Vaccine Initiative (IAVI) New York :: IAVI is a public-private partnership dedicated to ensuring the development and deployment of an
AIDS vaccine for the world. Partnering extensively with organizations across the globe, IAVI is leading AIDS vaccine research efforts from its network of labs, including the
IAVI AIDS Vaccine Design and Development Laboratory in Brooklyn. More than 127,000 people in New York State are currently living with HIV/AIDS.
Global Health R&D
{
A SMART THING FOR THE U.S.
THE RIGHT THING FOR THE WORLD.
ECONOMIC IMPACT
Where Does New York Rank?
INVESTMENT
STATE
RANK
$4,035,000,000
6
$10,518,000,000
8
Universities
$779,000,000
2
Non-profit
$299,000,000
3
Other*
$308,000,000
3
$15,939,000,000
6
SOURCE OF R&D FUNDING
Federal Government
Industry
Total
Source: National Science Foundation, National Patterns of R&D Resources, 2008
*Other represents funding from state and local governments and funding for Federally Funded Research and Development Centers from non-federal sources.
New York ranks 5th in the nation in population and 6th in the country in total R&D investment.
Less than one penny of every health dollar spent on research goes toward global health R&D.
Sources: United for Medical Research; US Census
New York Global Ties
Pfizer, headquartered in NYC, invests considerable resources globally and throughout New York State. As of 2010, Pfizer’s more than 780 strategic partnerships in
the US included 58 in New York, with more than half in NYC. Source: Pfizer.
New York City hosted 48.7 million tourists in 2010. Nearly 10 million, or 20%, of
those were from outside the US. Global health R&D helps ensure that New Yorkers
stay safe and healthy. Source: NYC Economic Development Corp.
During the 2009-10 academic year, more than 21,000 New York students studied
abroad. Investments in global health help ensure their well-being and that of future
generations of students. Source: US Global Leadership Council.
AIDS Vaccine Advocacy Coalition accelerates the development of AIDS vaccines
and biomedical HIV prevention research to fight the pandemic. While AVAC’s staff
is based in NYC, its work is carried out around the world, with a specific focus in
countries with active HIV prevention research. Source: AVAC.
New York-based global biopharmaceutical company Bristol-Myers Squibb
committed $3.6 billion to R&D in 2009. In partnership with Merck and Gilead, their
breakthrough 2006 HIV treatment Atripla is now the most prescribed HIV drug in
the U.S. and is used around the world. Sources: National Archives; BMS.
What New Yorkers
are saying
Important for New York to be
a Leader in Health Research
and Development
How important is it for New York to
be a leader in health research and
development?
90% Important
8% Not important
2% Don’t know
Source: New York Global Health Survey, January 2012.
JZ Analytics for Research!America.
New Yorkers Think
Global Health Research
Creates Jobs
Do you think global health research
creates jobs in New York?
53% Yes
21% No
26% Don’t know
Source: New York Global Health Survey, January 2012.
JZ Analytics for Research!America.
••••••••
“Americans can be proud that people around the world are living longer, healthier
lives because of the U.S. commitment to global health…[B]ut there are still far
too many people who die from conditions that are easily preventable. Continued
investments will help millions more live healthy and productive lives while
helping to protect our own country from health threats.”
— Tom Frieden, MD, MPH, Director, Centers for Disease Control and
Prevention, previously New York City Health Commissioner
1101 King Street, Suite 520
Alexandria, Virginia 22314
703.739.2577
Fax 703.739.2372
www.researchamerica.org
info@researchamerica.org